Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.Explore and learn more about Conference Series : World's leading Event Organizer
As per available reports about 16 Conferences,7 symposiums ,2 journals are presently dedicated exclusively to standardisation parenteral nutrition and about 2 articles are being published on standardisation parenteral nutrition.
Standardisation of parenteral nutrition formulations are routinely utilized in the neonatal medical aid units in Australia and New zealand. Parenteral nutrition (PN) has become Associate in Nursing integral a part of clinical management of terribly low birth weight premature neonates. Historically totally different elements of PN are prescribed separately considering needs of a personal newborn infant (IPN). additional recently, standardisation of parenteral nutrition formulations (SPN) for preterm neonates are assessed and will have blessings together with higher provision of nutrients, less prescription and administration errors, minimized risk of infection, and value savings. The recent introduction of triple-chamber bag that has total nutrient admixture for neonates could have extra advantage of minimized risk of contamination and simple administration.
Standardisation of parenteral nutrition process must be explored so as to enhance patient safety and clinical appropriateness, and to maximize resource potency. The same method could embrace use of standardized parenteral nutrition formulations (including standardized, industrial PN products) however conjointly includes aspects of ordering, labeling, screening, change of integrity, and administration of parenteral nutrition. A secure parenteral nutrition system should exist that minimizes procedural incidents and maximizes the power to fulfill individual patient needs..
Standardisation of parenteral nutrition could have advantages over IPN with relevance higher nutrient intake and weight gain; and fewer prescription errors and cost; while not inflicting important organic chemistry disturbance. Recently introduced ready-to-use all-in-one parenteral nutrition preparations for neonatal use could have extra advantages of simple administration and minimized risk of infection.
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and Importance:
The purpose of this report is to promote the safety and effectiveness of PN provision, and to clarify (and where possible simplify) the complicated pathway of events that begins with a decision to feed a patient intravenously and ends with the infusion of nutrients directly into the circulation.
Nutritional support is a fundamental element of care for many infants and children with a great variety of medical and surgical diagnoses. When nutritional requirements cannot be met, using the gastrointestinal tract (enteral nutrition), nutrients must be given intravenously as parenteral nutrition (PN). The clinical and nutritional need for PN requires careful assessment; any decision to start PN will depend on the underlying clinical condition and nutritional status of the patient. Prescribing, compounding and administration of PN are tasks that demand meticulous planning, effective communication and a breadth of specialist expertise from multidisciplinary teams of doctors, pharmacists and other members of the pharmacy team, dieticians, nurses and clinical scientists. Every stage of the process carries risks, and although large numbers of patients are fed intravenously without adverse events every year, occasionally serious incidents have occurred, some of which have resulted in patient deaths.
Parenteral nutrition (PN) has become an integral part of clinical management of very low birth weight premature neonates. Traditionally different components of PN are prescribed individually considering requirements of an individual neonate (IPN). More recently, standardised PN formulations (SPN) for preterm neonates have been assessed and may have advantages including better provision of nutrients, less prescription and administration errors, decreased risk of infection, and cost savings. The recent introduction of triple-chamber bag that provides total nutrient admixture for neonates may have additional advantage of decreased risk of contamination and ease of administration.
Market Analysis:
The Global Medical Nutrition market is expected to grow at a steady pace, clocking a CAGR of 6.7 percent during the period 2012-2016. The lack of standardization in reimbursement norms for medical nutrition products has rendered these products unaffordable to price-conscious consumers.Single User, $2,500,Five User, $2,800,Enterprise, $3,500 ,Global License, $10,000.
International symposium and workshops
List of Best International Conferences
Relevant Society and Associations
1. Parenteral Drug Associations
2. American Society for Parenteral and Enteral Nutrition
3. Australian Medical Association
4. American Pharmacists Association
5. American Association of Pharmaceutical Scientists
6. International Academy of Compounding Pharmacists
7. European Medicines Agency
8. American College of Clinical Pharmacy
9. European Society for Clinical Nutrition and Metabolism
10. American Society for Nutrition
Companies
1. AstraZeneca
2. Accredo Therapeutics
3.Actelion Pharmaceuticals US, Inc
4. Bayer HealthCare
5. Critical Care
6.Cané Medical Technology
7. CVS Caremark
8. CuraScript
9. Fairview Specialty Pharmacy
10.Gilead Sciences
11.Vivisol
12.AIM
13.Henry Schein
14.Snap Diagnostics
15.MediLexicon
16.Nicos Group Inc.
17.JEDMED
18.Bausch & Lomb Instruments
This page will be updated regularly.
This page was last updated on April 24, 2024